All lobbying filings

FGS Global (US) LLC (FKA FGH Holdings LLC)

FGS Global (US) LLC (FKA FGH Holdings LLC) filed a Q4 report for Skyhawk Therapeutics, Inc. on January 20, 2026, reporting $30,000 in lobbying income.

Lobbying for Skyhawk Therapeutics, Inc. · Biotech company

As filed: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) for SKYHAWK THERAPEUTICS, INC.

All filings by FGS Global (US) LLC (FKA FGH Holdings LLC) · Everything Skyhawk Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Taxation/Internal Revenue Code

Lobbying related to deductibility of research and development expenses.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.